Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Dual role of adenosine A2A receptor activation in wound healing

Oct. 29, 2003

Teva to commercialize OrCel in Israel

Oct. 28, 2003

Alefacept therapy beneficial in the treatment of psoriasis

Oct. 28, 2003

Polyphenon E (EGCg) improves preaged and damaged facial skin

Oct. 28, 2003

Topical bimosiamose studied in psoriasis and atopic dermatitis

Oct. 14, 2003

New topical antiinflammatory agents and their use described by Japan Energy

Oct. 14, 2003

Recombinant alpha1-antitrypsin enters proof-of-concept study for atopic dermatitis

Oct. 13, 2003

Successful completion of phase I trial of Tbeta4

Oct. 10, 2003

Biogen licenses rights to oral psoriasis product from Fumapharm

Oct. 6, 2003

Treatment completed in phase IIb trial of MBI-594AN for acne

Oct. 6, 2003

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....